InsidersTradesSigma
申报总数
公司
▲ 买入（3 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
3
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
+80.2%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Browse the full record of transactions filed by Usman Nassim, 董事长兼首席执行官. Officer active across 2 companies, notably Catalyst Biosciences, INC.. Aggregated, 8 filings have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €5k. History available since 9 August 2021. The latest transaction was disclosed on 28 June 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Usman Nassim
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
3,452 股@ US$6.935.5% 占其流量Common StockSEC:0001140361-24-032024:0
20,000 股@ US$6.9331.7% 占其流量Common StockSEC:0001140361-24-024125:0
20,000 股@ US$6.9331.6% 占其流量Common StockSEC:0001140361-24-017566:0
20,000 股@ US$6.9331.2% 占其流量Common StockSEC:0001140361-24-014164:0
24.541 股Series Y Preferred StockSEC:0001140361-23-042367:0
3,250 股@ US$0.4718.4% 占其流量Common StockSEC:0001209191-22-045256:0
标准退出：2022年11月7日 (T+90)
3,250 股@ US$0.4623.9% 占其流量Common StockSEC:0001209191-22-010407:0
标准退出：2022年5月10日 (T+90)
867 股@ US$3.6248.8% 占其流量Common StockSEC:0001209191-21-050759:0
标准退出：2021年11月7日 (T+90)
8 条申报中的 8 条
About Usman Nassim
USMAN NASSIM is President & CEO. He has 8 filings in total, and within the recent filings held, buys total 5479 EUR and sells total 0 EUR, from 2021-08-11 to 2024-07-01. His listed companies are GYRE THERAPEUTICS, INC., where he is a Director, and Catalyst Biosciences, INC., where he is President & CEO. The most common transaction nature is Option exercise.
